Hémorragie sous-arachnoïdienne: épidémiologie, prédisposition, présentation clinique

Translated title of the contribution: Subarachnoid haemorrhage: epidemiology, genomic, clinical presentation

G. Audibert*, S. Bousquet, C. Charpentier, Y. Devaux, P. M. Mertes

*Corresponding author for this work

    Research output: Contribution to journalArticleResearchpeer-review

    13 Citations (Scopus)

    Abstract

    Subarachnoid haemorrhage (SAH) accounts for 1 to 7% of all strokes. In France, the range of incidence of SAH varies between 3 and 8/100 000 inhabitants. Global mortality lies around 40%, including 70% during the first week. The size of more than 90% of all aneurysms is less than 10 mm. In more than 90% of the patients; SAH is sporadic and a familial screening is warranted only after SAH occurring in 2 first-degree relatives. The main risk factors of SAH are tobacco, arterial hypertension and alcohol abuse. Genetic susceptibility may exist: it could involve several genes, the expression of which would characterize pathophysiological pathways implicated in the disease. This could be identified using genomic technique of microarrays, which could explore all the genome, simply using a sample of peripheral venous blood. For example, in the future, this approach could help to identify patients who are at high risk to develop vasospasm after SAH.

    Translated title of the contributionSubarachnoid haemorrhage: epidemiology, genomic, clinical presentation
    Original languageFrench
    Pages (from-to)943-947
    Number of pages5
    JournalAnnales Francaises d'Anesthesie et de Reanimation
    Volume26
    Issue number11
    DOIs
    Publication statusPublished - Nov 2007

    Keywords

    • Epidemiology
    • Familial forms
    • Genomic
    • Microarrays
    • Risk factors
    • Subarachnoid haemorrhage

    Fingerprint

    Dive into the research topics of 'Subarachnoid haemorrhage: epidemiology, genomic, clinical presentation'. Together they form a unique fingerprint.

    Cite this